Table 2.
Formulation | Drug dissolved (%) ± S.D. | |
---|---|---|
Q15 | Q120 | |
KPD | 15.21 ± 0.05 | 15.39 ± 0.14 |
KPD/HPMC (1:0.5) | 24.58 ± 1.55 | 44.83 ± 1.09 |
KPD/HPMC (1:1) | 34.27 ± 3.45 | 52.72 ± 4.45 |
KPD/HPMC (1:2) | 43.71 ± 4.48 | 62.11 ± 2.17 |
KPD/HPMC (1:4) | 21.20 ± 1.52 | 34.23 ± 1.23 |
KPD/PVA-co-PEG (1:0.5) | 9.43 ± 0.10 | 12.07 ± 0.15 |
KPD/PVA-co-PEG (1:1) | 75.74 ± 2.56 | 85.83 ± 1.10 |
KPD/PVA-co-PEG (1:2) | 32.79 ± 1.46 | 37.08 ± 1.39 |
KPD/PVA-co-PEG (1:4) | 8.83 ± 1.50 | 8.18 ± 0.08 |